Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Roc-King Onwards: Intraepithelial Lymphocyte Counts, Distribution & Role in Coeliac Disease Mucosal Interpretation Publisher Pubmed



Rostami K1 ; Marsh MN2, 3 ; Johnson MW2 ; Mohaghegh H4 ; Heal C5 ; Holmes G6 ; Ensari A7 ; Aldulaimi D8 ; Bancel B9 ; Bassotti G10 ; Bateman A11 ; Becheanu G12 ; Bozzola A13 ; Carroccio A14 Show All Authors
Authors
  1. Rostami K1
  2. Marsh MN2, 3
  3. Johnson MW2
  4. Mohaghegh H4
  5. Heal C5
  6. Holmes G6
  7. Ensari A7
  8. Aldulaimi D8
  9. Bancel B9
  10. Bassotti G10
  11. Bateman A11
  12. Becheanu G12
  13. Bozzola A13
  14. Carroccio A14
  15. Catassi C15
  16. Ciacci C16
  17. Ciobanu A12
  18. Danciu M17
  19. Derakhshan MH18, 19
  20. Elli L20
  21. Ferrero S20
  22. Fiorentino M21
  23. Fiorino M14
  24. Ganji A22
  25. Ghaffarzadehgan K23
  26. Going JJ24
  27. Ishaq S25
  28. Mandolesi A15
  29. Mathews S1
  30. Maxim R17
  31. Mulder CJ26
  32. Neefjesborst A26
  33. Robert M27
  34. Russo I16
  35. Rostaminejad M4
  36. Sidoni A10
  37. Sotoudeh M19
  38. Villanacci V13
  39. Volta U21
  40. Zali MR4
  41. Srivastava A28

Source: Gut Published:2017


Abstract

Objectives Counting intraepithelial lymphocytes (IEL) is central to the histological diagnosis of coeliac disease (CD), but no definitive 'normal' IEL range has ever been published. In this multicentre study, receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off between normal and CD (Marsh III lesion) duodenal mucosa, based on IEL counts on >400 mucosal biopsy specimens. Design The study was designed at the International Meeting on Digestive Pathology, Bucharest 2015. Investigators from 19 centres, eight countries of three continents, recruited 198 patients with Marsh III histology and 203 controls and used one agreed protocol to count IEL/100 enterocytes in well-oriented duodenal biopsies. Demographic and serological data were also collected. Results The mean ages of CD and control groups were 45.5 (neonate to 82) and 38.3 (2-88) years. Mean IEL count was 54±18/100 enterocytes in CD and 13±8 in normal controls (p=0.0001). ROC analysis indicated an optimal cut-off point of 25 IEL/100 enterocytes, with 99% sensitivity, 92% specificity and 99.5% area under the curve. Other cut-offs between 20 and 40 IEL were less discriminatory. Additionally, there was a sufficiently high number of biopsies to explore IEL counts across the subclassification of the Marsh III lesion. Conclusion Our ROC curve analyses demonstrate that for Marsh III lesions, a cut-off of 25 IEL/100 enterocytes optimises discrimination between normal control and CD biopsies. No differences in IEL counts were found between Marsh III a, b and c lesions. There was an indication of a continuously graded dose-response by IEL to environmental (gluten) antigenic influence. © Article author(s).